Weill Cornell Chelsea CRS is a clinical research site located in New York, New York, United States 10011.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Weill Cornell Chelsea CRS has participated in 22 clinical trials with 4 currently active.
Therapeutic areas: HIV Infections, Sexually Transmitted Diseases, HIV-1.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Weill Cornell Chelsea CRS has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Weill Cornell Chelsea CRS has 22 clinical trials on record, with 4 currently active. Their work covers HIV Infections, Sexually Transmitted Diseases, HIV-1.
Yes — Weill Cornell Chelsea CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.